Growth Metrics

BioNexus Gene Lab (BGLC) Long-Term Deferred Tax (2024)

BioNexus Gene Lab's Long-Term Deferred Tax history spans 1 years, with the latest figure at $9.4 million for Q4 2024.

  • Quarterly results put Long-Term Deferred Tax at $9.4 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $9.4 million (changed N/A YoY), and the annual figure for FY2024 was $9.4 million, changed.
  • Long-Term Deferred Tax for Q4 2024 was $9.4 million at BioNexus Gene Lab.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $9.4 million in Q4 2024 to a low of $9.4 million in Q4 2024.